Login to Your Account

Other News To Note

Friday, December 14, 2012
• Genmab A/S, of Copenhagen, Denmark, said it reached the third preclinical milestone in its collaboration with H. Lundbeck A/S, also of Copenhagen, triggering a €1 million (US$1.3 million) payment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription